PureTech Health PLC Holding(s) in Company (0566S)
July 06 2020 - 2:00AM
UK Regulatory
TIDMPRTC TIDMJUP
RNS Number : 0566S
PureTech Health PLC
06 July 2020
TR-1: S tandard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and
to the FCA in Microsoft Word format if possible) (i)
1a. Identity of the issuer or the Puretech Health PLC
underlying issuer of existing shares
to which voting rights are attached
(ii) :
--------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer (please mark with
an "X" if appropriate)
Non-UK issuer
----------
2. Reason for the notification (please mark the appropriate box or boxes
with an "X")
An acquisition or disposal of voting rights
----------
An acquisition or disposal of financial instruments
----------
An event changing the breakdown of voting rights
----------
Other (please specify)(iii) : As of 1 July 2020, Merian Global X
Investors Limited is owned by Jupiter Fund Management Plc.
Any positions in Merian Global Investors Limited are transferred
to Jupiter Fund Management Plc.
The disclosure also highlights the full chain of controlled
undertakings through which the voting rights and/or the financial
instruments are effectively held starting with the ultimate
controlling natural person or legal entity detailed within
Section 9, following this change of ownership.
----------
3. Details of person subject to the notification obligation (iv)
Name Jupiter Fund Management Plc
City and country of registered office
(if applicable)
4. Full name of shareholder(s) (if different from 3.) (v)
Name Northern Trust
--------------------------------------------
City and country of registered office
(if applicable)
--------------------------------------------
5. Date on which the threshold was 01/07/2020
crossed or reached (vi) :
--------------------------------------------
6. Date on which issuer notified (DD/MM/YYYY): 03/07/2020
--------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting % of voting rights Total of both Total number
rights attached through financial in % (8.A + of voting rights
to shares (total instruments 8.B) of issuer (vii)
of 8. A) (total of 8.B
1 + 8.B 2)
------------------ --------------------- -------------- --------------------
Resulting situation
on the date
on which threshold
was crossed
or reached 5.53% 0% 5.53% 285,512,461
------------------ --------------------- -------------- --------------------
Position of N/A N/A N/A
previous notification
(if
applicable)
------------------ --------------------- -------------- --------------------
8. Notified details of the resulting situation on the date on which
the threshold was crossed or reached (viii)
A: Voting rights attached to shares
Class/type of Number of voting rights % of voting rights
shares (ix)
ISIN code (if
possible)
Direct Indirect Direct Indirect
(Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) (DTR5.1) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.2.1)
----------------------------
GB00BY2Z0H74 N/A 15,799,957 N/A 5.53%
----------------------- ---------------------------- ------------------------- ---------------------
SUBTOTAL 8. A 15,799,957 5.53%
----------------------------------------------------- ------------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC
(DTR5.3.1.1 (a))
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion Period rights that may rights
instrument (x) (xi) be acquired if
the instrument
is
exercised/converted.
------------- -------------------------------- ------------------------------- ---------------------
N/A N/A N/A N/A N/A
------------- -------------------------------- ------------------------------- ---------------------
SUBTOTAL 8. B 1 N/A N/A
-------------------------------- ------------------------------- ---------------------
B 2: Financial Instruments with similar economic effect according to
Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of Expiration Exercise/ Physical or Number of % of voting
financial date (x) Conversion cash voting rights rights
instrument Period (xi) settlement
(xii)
------------------ -------------------- --------------------- --------------------
N/A N/A N/A N/A N/A N/A
------------------ -------------------- --------------------- --------------------
SUBTOTAL 8.B.2 N/A N/A
--------------------- --------------------
9. Information in relation to the person subject to the notification
obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled
by any natural person or legal entity and does not control any
other undertaking(s) holding directly or indirectly an interest
in the (underlying) issuer (xiii)
Full chain of controlled undertakings through which the voting X
rights and/or the
financial instruments are effectively held starting with the
ultimate controlling natural person or legal entity (xiv) (please
add additional rows as necessary)
Name % of voting rights % of voting rights Total of both if
if it equals or is through financial it equals or is
higher than the notifiable instruments if it higher than the
threshold equals or is higher notifiable threshold
than the notifiable
threshold
---------------------------- --------------------- ------------------------
Jupiter Fund Management
Plc
---------------------------- --------------------- ------------------------
Jupiter Fund Management
Group Limited
---------------------------- --------------------- ------------------------
Jupiter Asset
Management Group
Limited
---------------------------- --------------------- ------------------------
Knightsbridge
Asset Management
Limited
---------------------------- --------------------- ------------------------
Jupiter Investment
Management Group
Limited
---------------------------- --------------------- ------------------------
Jupiter Asset
Management Limited 5.53% 0% 5.53%
---------------------------- --------------------- ------------------------
Jupiter Fund Management
Plc
---------------------------- --------------------- ------------------------
Merian Global
Investors Limited
---------------------------- --------------------- ------------------------
Merian Global
Investors (Jersey)
Limited
---------------------------- --------------------- ------------------------
Merian Global
Investors (Finance)
Limited
---------------------------- --------------------- ------------------------
Merian Global
Investors Holdings
Limited
---------------------------- --------------------- ------------------------
Merian Global
Investors (UK)
Limited
---------------------------- --------------------- ------------------------
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights N/A
held
----
The date until which the voting rights N/A
will be held
----
11. Additional information (xvi)
Contact : Claire Rodway
Telephone Number : 0203 817 1441
Place of completion London, UK
Date of completion 3(rd) July 2020
----------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
HOLRAMLTMTJMBRM
(END) Dow Jones Newswires
July 06, 2020 02:00 ET (06:00 GMT)
Puretech Health (LSE:PRTC)
Historical Stock Chart
From Oct 2024 to Nov 2024
Puretech Health (LSE:PRTC)
Historical Stock Chart
From Nov 2023 to Nov 2024
